PMOS, Polyendocrine metabolic ovarian syndrome
This information is most valuable when discussed with a qualified healthcare provider familiar with your complete medical history
Common adverse effects of GLP-1 receptor agonists include: Gastrointestinal symptoms (nausea, vomiting, diarrhoea, constipation)usually mild to moderate and often diminishing over time Injection site reactions Headache Fatigue More serious but rare adverse effects have been identified, including: Pancreatitis patients should seek urgent medical advice for severe, persistent abdominal pain (with or without vomiting) Gallbladder disease symptoms include upper right abdominal pain and jaundice Diabetic retinopathy complications particularly with rapid HbA1c reduction in patients with pre-existing retinopathy Dehydration and acute kidney injury from persistent gastrointestinal symptoms When combined with sulfonylureas or insulin, GLP-1 receptor agonists increase the risk of hypoglycaemia
symptoms suggesting diabetic ketoacidosisincluding excessive thirst, frequent urination, nausea, vomiting, abdominal pain, and fruity-smelling breath (requires emergency care regardless of diabetes type)
What comes out of the brush is an almost tacky substance that takes a bit of work to spread, creating a drag on the brush
Young, healthy individuals have an abundance of GHK, but as humans age, GHK diminishes 1
.jpg)
